Hmdb loader
Record Information
Version5.0
StatusDetected but not Quantified
Creation Date2021-09-11 07:23:31 UTC
Update Date2021-09-26 23:01:50 UTC
HMDB IDHMDB0250388
Secondary Accession NumbersNone
Metabolite Identification
Common NameCobimetinib
DescriptionCobimetinib belongs to the class of organic compounds known as anthranilamides. These are aromatic compound containing a benzene carboxamide moiety that carries an amine group at the 2-position of the benzene ring. Based on a literature review a significant number of articles have been published on Cobimetinib. This compound has been identified in human blood as reported by (PMID: 31557052 ). Cobimetinib is not a naturally occurring metabolite and is only found in those individuals exposed to this compound or its derivatives. Technically Cobimetinib is part of the human exposome. The exposome can be defined as the collection of all the exposures of an individual in a lifetime and how those exposures relate to health. An individual's exposure begins before birth and includes insults from environmental and occupational sources.
Structure
Thumb
SynonymsNot Available
Chemical FormulaC21H21F3IN3O2
Average Molecular Weight531.318
Monoisotopic Molecular Weight531.06306
IUPAC Name1-{3,4-difluoro-2-[(2-fluoro-4-iodophenyl)amino]benzoyl}-3-(piperidin-2-yl)azetidin-3-ol
Traditional Name1-{3,4-difluoro-2-[(2-fluoro-4-iodophenyl)amino]benzoyl}-3-(piperidin-2-yl)azetidin-3-ol
CAS Registry NumberNot Available
SMILES
OC1(CN(C1)C(=O)C1=C(NC2=C(F)C=C(I)C=C2)C(F)=C(F)C=C1)C1CCCCN1
InChI Identifier
InChI=1S/C21H21F3IN3O2/c22-14-6-5-13(19(18(14)24)27-16-7-4-12(25)9-15(16)23)20(29)28-10-21(30,11-28)17-3-1-2-8-26-17/h4-7,9,17,26-27,30H,1-3,8,10-11H2
InChI KeyBSMCAPRUBJMWDF-UHFFFAOYSA-N
Chemical Taxonomy
Description Belongs to the class of organic compounds known as anthranilamides. These are aromatic compound containing a benzene carboxamide moiety that carries an amine group at the 2-position of the benzene ring.
KingdomOrganic compounds
Super ClassBenzenoids
ClassBenzene and substituted derivatives
Sub ClassBenzoic acids and derivatives
Direct ParentAnthranilamides
Alternative Parents
Substituents
  • Aminobenzamide
  • Anthranilamide
  • Aminobenzoic acid or derivatives
  • 3-halobenzoic acid or derivatives
  • 2-aminobenzamide
  • 4-halobenzoic acid or derivatives
  • Halobenzoic acid or derivatives
  • Benzoyl
  • Aniline or substituted anilines
  • Iodobenzene
  • Halobenzene
  • Fluorobenzene
  • Aryl fluoride
  • Piperidine
  • Aryl halide
  • Aryl iodide
  • Tertiary carboxylic acid amide
  • Tertiary alcohol
  • Vinylogous amide
  • 1,2-aminoalcohol
  • Amino acid or derivatives
  • Azetidine
  • Carboxamide group
  • Azacycle
  • Secondary amine
  • Organoheterocyclic compound
  • Secondary aliphatic amine
  • Carboxylic acid derivative
  • Organonitrogen compound
  • Alcohol
  • Organooxygen compound
  • Amine
  • Hydrocarbon derivative
  • Organic oxide
  • Organopnictogen compound
  • Organic oxygen compound
  • Organic nitrogen compound
  • Organohalogen compound
  • Organofluoride
  • Organoiodide
  • Aromatic heteromonocyclic compound
Molecular FrameworkAromatic heteromonocyclic compounds
External DescriptorsNot Available
Ontology
Physiological effectNot Available
Disposition
ProcessNot Available
RoleNot Available
Physical Properties
StateNot Available
Experimental Molecular Properties
PropertyValueReference
Melting PointNot AvailableNot Available
Boiling PointNot AvailableNot Available
Water SolubilityNot AvailableNot Available
LogPNot AvailableNot Available
Experimental Chromatographic PropertiesNot Available
Predicted Molecular Properties
PropertyValueSource
logP3.35ALOGPS
logP5.04ChemAxon
logS-4.1ALOGPS
pKa (Strongest Acidic)13.37ChemAxon
pKa (Strongest Basic)9.76ChemAxon
Physiological Charge1ChemAxon
Hydrogen Acceptor Count4ChemAxon
Hydrogen Donor Count3ChemAxon
Polar Surface Area64.6 ŲChemAxon
Rotatable Bond Count4ChemAxon
Refractivity115.85 m³·mol⁻¹ChemAxon
Polarizability45.26 ųChemAxon
Number of Rings4ChemAxon
BioavailabilityNoChemAxon
Rule of FiveNoChemAxon
Ghose FilterNoChemAxon
Veber's RuleNoChemAxon
MDDR-like RuleNoChemAxon
Predicted Chromatographic Properties

Predicted Collision Cross Sections

PredictorAdduct TypeCCS Value (Å2)Reference
DeepCCS[M+H]+210.19830932474
DeepCCS[M-H]-207.8430932474
DeepCCS[M-2H]-241.58130932474
DeepCCS[M+Na]+216.68230932474
AllCCS[M+H]+205.732859911
AllCCS[M+H-H2O]+203.932859911
AllCCS[M+NH4]+207.332859911
AllCCS[M+Na]+207.732859911
AllCCS[M-H]-200.132859911
AllCCS[M+Na-2H]-201.032859911
AllCCS[M+HCOO]-202.132859911

Predicted Kovats Retention Indices

Underivatized

MetaboliteSMILESKovats RI ValueColumn TypeReference
CobimetinibOC1(CN(C1)C(=O)C1=C(NC2=C(F)C=C(I)C=C2)C(F)=C(F)C=C1)C1CCCCN13796.0Standard polar33892256
CobimetinibOC1(CN(C1)C(=O)C1=C(NC2=C(F)C=C(I)C=C2)C(F)=C(F)C=C1)C1CCCCN13333.8Standard non polar33892256
CobimetinibOC1(CN(C1)C(=O)C1=C(NC2=C(F)C=C(I)C=C2)C(F)=C(F)C=C1)C1CCCCN13489.2Semi standard non polar33892256

Derivatized

Derivative Name / StructureSMILESKovats RI ValueColumn TypeReference
Cobimetinib,2TMS,isomer #1C[Si](C)(C)OC1(C2CCCCN2[Si](C)(C)C)CN(C(=O)C2=CC=C(F)C(F)=C2NC2=CC=C(I)C=C2F)C13435.9Semi standard non polar33892256
Cobimetinib,2TMS,isomer #1C[Si](C)(C)OC1(C2CCCCN2[Si](C)(C)C)CN(C(=O)C2=CC=C(F)C(F)=C2NC2=CC=C(I)C=C2F)C13271.6Standard non polar33892256
Cobimetinib,2TMS,isomer #1C[Si](C)(C)OC1(C2CCCCN2[Si](C)(C)C)CN(C(=O)C2=CC=C(F)C(F)=C2NC2=CC=C(I)C=C2F)C13886.2Standard polar33892256
Cobimetinib,2TMS,isomer #2C[Si](C)(C)OC1(C2CCCCN2)CN(C(=O)C2=CC=C(F)C(F)=C2N(C2=CC=C(I)C=C2F)[Si](C)(C)C)C13324.5Semi standard non polar33892256
Cobimetinib,2TMS,isomer #2C[Si](C)(C)OC1(C2CCCCN2)CN(C(=O)C2=CC=C(F)C(F)=C2N(C2=CC=C(I)C=C2F)[Si](C)(C)C)C13259.5Standard non polar33892256
Cobimetinib,2TMS,isomer #2C[Si](C)(C)OC1(C2CCCCN2)CN(C(=O)C2=CC=C(F)C(F)=C2N(C2=CC=C(I)C=C2F)[Si](C)(C)C)C13659.7Standard polar33892256
Cobimetinib,2TMS,isomer #3C[Si](C)(C)N(C1=CC=C(I)C=C1F)C1=C(F)C(F)=CC=C1C(=O)N1CC(O)(C2CCCCN2[Si](C)(C)C)C13337.1Semi standard non polar33892256
Cobimetinib,2TMS,isomer #3C[Si](C)(C)N(C1=CC=C(I)C=C1F)C1=C(F)C(F)=CC=C1C(=O)N1CC(O)(C2CCCCN2[Si](C)(C)C)C13283.9Standard non polar33892256
Cobimetinib,2TMS,isomer #3C[Si](C)(C)N(C1=CC=C(I)C=C1F)C1=C(F)C(F)=CC=C1C(=O)N1CC(O)(C2CCCCN2[Si](C)(C)C)C13805.8Standard polar33892256
Cobimetinib,3TMS,isomer #1C[Si](C)(C)OC1(C2CCCCN2[Si](C)(C)C)CN(C(=O)C2=CC=C(F)C(F)=C2N(C2=CC=C(I)C=C2F)[Si](C)(C)C)C13351.9Semi standard non polar33892256
Cobimetinib,3TMS,isomer #1C[Si](C)(C)OC1(C2CCCCN2[Si](C)(C)C)CN(C(=O)C2=CC=C(F)C(F)=C2N(C2=CC=C(I)C=C2F)[Si](C)(C)C)C13325.6Standard non polar33892256
Cobimetinib,3TMS,isomer #1C[Si](C)(C)OC1(C2CCCCN2[Si](C)(C)C)CN(C(=O)C2=CC=C(F)C(F)=C2N(C2=CC=C(I)C=C2F)[Si](C)(C)C)C13576.2Standard polar33892256
Cobimetinib,2TBDMS,isomer #1CC(C)(C)[Si](C)(C)OC1(C2CCCCN2[Si](C)(C)C(C)(C)C)CN(C(=O)C2=CC=C(F)C(F)=C2NC2=CC=C(I)C=C2F)C13876.3Semi standard non polar33892256
Cobimetinib,2TBDMS,isomer #1CC(C)(C)[Si](C)(C)OC1(C2CCCCN2[Si](C)(C)C(C)(C)C)CN(C(=O)C2=CC=C(F)C(F)=C2NC2=CC=C(I)C=C2F)C13643.8Standard non polar33892256
Cobimetinib,2TBDMS,isomer #1CC(C)(C)[Si](C)(C)OC1(C2CCCCN2[Si](C)(C)C(C)(C)C)CN(C(=O)C2=CC=C(F)C(F)=C2NC2=CC=C(I)C=C2F)C13971.9Standard polar33892256
Cobimetinib,2TBDMS,isomer #2CC(C)(C)[Si](C)(C)OC1(C2CCCCN2)CN(C(=O)C2=CC=C(F)C(F)=C2N(C2=CC=C(I)C=C2F)[Si](C)(C)C(C)(C)C)C13727.4Semi standard non polar33892256
Cobimetinib,2TBDMS,isomer #2CC(C)(C)[Si](C)(C)OC1(C2CCCCN2)CN(C(=O)C2=CC=C(F)C(F)=C2N(C2=CC=C(I)C=C2F)[Si](C)(C)C(C)(C)C)C13663.3Standard non polar33892256
Cobimetinib,2TBDMS,isomer #2CC(C)(C)[Si](C)(C)OC1(C2CCCCN2)CN(C(=O)C2=CC=C(F)C(F)=C2N(C2=CC=C(I)C=C2F)[Si](C)(C)C(C)(C)C)C13734.9Standard polar33892256
Cobimetinib,2TBDMS,isomer #3CC(C)(C)[Si](C)(C)N(C1=CC=C(I)C=C1F)C1=C(F)C(F)=CC=C1C(=O)N1CC(O)(C2CCCCN2[Si](C)(C)C(C)(C)C)C13791.4Semi standard non polar33892256
Cobimetinib,2TBDMS,isomer #3CC(C)(C)[Si](C)(C)N(C1=CC=C(I)C=C1F)C1=C(F)C(F)=CC=C1C(=O)N1CC(O)(C2CCCCN2[Si](C)(C)C(C)(C)C)C13657.6Standard non polar33892256
Cobimetinib,2TBDMS,isomer #3CC(C)(C)[Si](C)(C)N(C1=CC=C(I)C=C1F)C1=C(F)C(F)=CC=C1C(=O)N1CC(O)(C2CCCCN2[Si](C)(C)C(C)(C)C)C13920.0Standard polar33892256
Cobimetinib,3TBDMS,isomer #1CC(C)(C)[Si](C)(C)OC1(C2CCCCN2[Si](C)(C)C(C)(C)C)CN(C(=O)C2=CC=C(F)C(F)=C2N(C2=CC=C(I)C=C2F)[Si](C)(C)C(C)(C)C)C13983.2Semi standard non polar33892256
Cobimetinib,3TBDMS,isomer #1CC(C)(C)[Si](C)(C)OC1(C2CCCCN2[Si](C)(C)C(C)(C)C)CN(C(=O)C2=CC=C(F)C(F)=C2N(C2=CC=C(I)C=C2F)[Si](C)(C)C(C)(C)C)C13865.6Standard non polar33892256
Cobimetinib,3TBDMS,isomer #1CC(C)(C)[Si](C)(C)OC1(C2CCCCN2[Si](C)(C)C(C)(C)C)CN(C(=O)C2=CC=C(F)C(F)=C2N(C2=CC=C(I)C=C2F)[Si](C)(C)C(C)(C)C)C13726.6Standard polar33892256
Spectra

GC-MS Spectra

Spectrum TypeDescriptionSplash KeyDeposition DateSourceView
Predicted GC-MSPredicted GC-MS Spectrum - Cobimetinib GC-MS (TMS_1_1) - 70eV, PositiveNot Available2021-11-03Wishart LabView Spectrum
Predicted GC-MSPredicted GC-MS Spectrum - Cobimetinib GC-MS (TMS_1_2) - 70eV, PositiveNot Available2021-11-03Wishart LabView Spectrum
Predicted GC-MSPredicted GC-MS Spectrum - Cobimetinib GC-MS (TMS_1_3) - 70eV, PositiveNot Available2021-11-03Wishart LabView Spectrum
Predicted GC-MSPredicted GC-MS Spectrum - Cobimetinib GC-MS (TBDMS_1_1) - 70eV, PositiveNot Available2021-11-03Wishart LabView Spectrum
Predicted GC-MSPredicted GC-MS Spectrum - Cobimetinib GC-MS (TBDMS_1_2) - 70eV, PositiveNot Available2021-11-03Wishart LabView Spectrum
Predicted GC-MSPredicted GC-MS Spectrum - Cobimetinib GC-MS (TBDMS_1_3) - 70eV, PositiveNot Available2021-11-03Wishart LabView Spectrum

MS/MS Spectra

Spectrum TypeDescriptionSplash KeyDeposition DateSourceView
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Cobimetinib 10V, Positive-QTOFsplash10-001i-0000090000-cddc2d7ac7cf2a9c90612021-10-12Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Cobimetinib 20V, Positive-QTOFsplash10-001i-0202290000-ade917d8f2b35c13de7c2021-10-12Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Cobimetinib 40V, Positive-QTOFsplash10-0gz0-1914340000-3617b697d1699aba230a2021-10-12Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Cobimetinib 10V, Negative-QTOFsplash10-001i-0000090000-0b4d5628fc60eca548972021-10-12Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Cobimetinib 20V, Negative-QTOFsplash10-01q9-0200190000-777a59e2fcf5ee787e172021-10-12Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Cobimetinib 40V, Negative-QTOFsplash10-004i-3903440000-78e54c122000cf9613ed2021-10-12Wishart LabView Spectrum
Biological Properties
Cellular LocationsNot Available
Biospecimen Locations
  • Blood
Tissue LocationsNot Available
Pathways
Normal Concentrations
BiospecimenStatusValueAgeSexConditionReferenceDetails
BloodDetected but not QuantifiedNot QuantifiedNot SpecifiedNot SpecifiedNormal details
Abnormal Concentrations
Not Available
Associated Disorders and Diseases
Disease ReferencesNone
Associated OMIM IDsNone
DrugBank IDNot Available
Phenol Explorer Compound IDNot Available
FooDB IDNot Available
KNApSAcK IDNot Available
Chemspider ID28637758
KEGG Compound IDNot Available
BioCyc IDNot Available
BiGG IDNot Available
Wikipedia LinkCobimetinib
METLIN IDNot Available
PubChem Compound51038893
PDB IDNot Available
ChEBI IDNot Available
Food Biomarker OntologyNot Available
VMH IDNot Available
MarkerDB IDNot Available
Good Scents IDNot Available
References
Synthesis ReferenceNot Available
Material Safety Data Sheet (MSDS)Not Available
General References
  1. Barupal DK, Fiehn O: Generating the Blood Exposome Database Using a Comprehensive Text Mining and Database Fusion Approach. Environ Health Perspect. 2019 Sep;127(9):97008. doi: 10.1289/EHP4713. Epub 2019 Sep 26. [PubMed:31557052 ]